KPV 10 MG

KPV is a alpha-MSH-derived tripeptide intended for controlled laboratory work. It is studied in experimental systems involving inflammatory-response, epithelial-barrier, microbial, and immune-signaling models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.

Research areas include:
• NF-kappaB and inflammatory-response pathways
• Intestinal and epithelial-barrier models
• Innate immune and microbial-response studies
• Skin and mucosal tissue models

Research limitations and safety:
• Published evidence and human safety data may be limited; composition, identity, purity, and experimental controls should be independently verified.
• No dosing, administration, or therapeutic-use guidance is provided.

being sold for research only.